Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.272100
-0.0060-2.16%
At Close: -
$0.271000
-0.0011-0.40%
After Hours: 7:46 PM EDT
15 minutes delayed
Comments
Loading...
TransCode Therapeutics (RNAZ) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Speculative
TransCode Therapeutics (NASDAQ:RNAZ) Stock Quotes, Forecast and News Summary
TransCode Therapeutics Stock (NASDAQ: RNAZ) stock price, news, charts, stock research, profile.
| Open | $0.29 |
| Close | $0.27 |
| Volume / Avg. | 309.75K / 1.06M |
| Day Range | $0.27 - $0.29 |
| 52 Wk Range | 0.22 - 128.00 |
| Market Cap | $4.68M |
| P/E Ratio | 0.00 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 33 |
| Short Interest | 9.48% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About TransCode Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disea...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy TransCode Therapeutics (RNAZ) stock?
You can purchase shares of TransCode Therapeutics (NASDAQ:RNAZ) through any online brokerage.
Who are TransCode Therapeutics (RNAZ) competitors?
Other companies in TransCode Therapeutics’s space includes: Virios Therapeutics (NASDAQ:VIRI), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI) and Trevena (NASDAQ:TRVN).
What is the forecast, or price target, for TransCode Therapeutics (RNAZ) stock?
TransCode Therapeutics has a consensus price target of $3.00.
What is the current price for TransCode Therapeutics (RNAZ)?
The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $0.271 last updated August 23, 2024 at 7:46 PM EDT.
Does TransCode Therapeutics (RNAZ) pay a dividend?
There are no upcoming dividends for TransCode Therapeutics.
When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?
TransCode Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is TransCode Therapeutics (RNAZ) going to split?
There is no upcoming split for TransCode Therapeutics.
What sector and industry does TransCode Therapeutics (RNAZ) operate in?
TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.